The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics.
Bots ML, Evans GW, Riley W, Meijer R, McBride KH, Paskett ED, Helmond FA, Grobbee DE. The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics. Control Clin Trials. 2003 Dec; 24(6):752-75.